Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:developedBy |
gptkb:Magenta_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
MGTA-456
|
| gptkbp:intendedUse |
hematopoietic stem cell mobilization
|
| gptkbp:mechanismOfAction |
gptkb:monoclonal_antibody
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
gptkb:CD117_(c-Kit)
|
| gptkbp:therapeuticArea |
hematology
|
| gptkbp:usedFor |
preparation for stem cell transplant
|
| gptkbp:bfsParent |
gptkb:Magenta_Therapeutics
|
| gptkbp:bfsLayer |
6
|